Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx Inc COMMON STOCK | 223,486 | 223,486 | 0 | $14.57M | $25.66M | 84.07% | +$11.09M |
| Kymera Therapeutics, Inc.(KYMR) | 19,648 | 19,648 | 0 | $1.53M | $1.64M | 5.36% | +$107.7K |
| Seer, Inc.CL A(SEER) | 816,375 | 816,375 | 0 | $1.49M | $1.54M | 5.05% | +$49.0K |
| Rallybio Corporation(RLYB) | 0 | 94,334 | +94,334 | $0 | $846.2K | 2.77% | +$846.2K |
| Sutro Biopharma, Inc.(STRO) | 17,500 | 17,500 | 0 | $202.5K | $435.9K | 1.43% | +$233.4K |
| Xilio Therapeutics, Inc.(XLO) | 0 | 47,695 | +47,695 | $0 | $401.1K | 1.31% | +$401.1K |
| Rapt Therapeutics Inc | 12,437 | 0 | -12,437 | $421.2K | $0 | — | -$421.2K |
| Rallybio Corporation(RLYB) | 754,678 | 0 | -754,678 | $4.14M | $0 | — | -$4.14M |
| Xilio Therapeutics, Inc.(XLO) | 667,742 | 0 | -667,742 | $427.5K | $0 | — | -$427.5K |